Rapid clinical stabilization following eculizumab therapy in severe anti-NMDAR encephalitis.
It is suggested that complement inhibition may facilitate rapid neurological recovery and may represent a potential therapeutic strategy for selected patients with severe anti-NMDAR encephalitis.